Granulomatous amebic encephalitis is a rare necrotizing infection of the CNS that occurs most commonly in immunocompromised individuals and is usually fatal. It is difficult to diagnose as the clinical symptoms and radiographic findings are often mistaken for other bacterial, viral, fungal, or protozoan infections. Herein, we present the case of a 69-year-old heart transplant recipient who suffered fulminant neurological decline $5 months after transplant. Extensive radiographic and laboratory testing did not provide a definite anatomic diagnosis and, despite aggressive clinical treatment, he died. An autopsy examination demonstrated numerous brain abscesses which contained amebic trophozoites and cysts. An indirect immunofluorescence assay performed at the Centers for Disease Control confirmed the presence of Acanthamoeba species. To the best of our knowledge, only 13 other cases of Acanthamoeba amebic encephalitis have been reported in patients who have received solid organ transplants and this is the second case reported in a heart transplant recipient. This case emphasizes that amebic encephalitis should be in the differential diagnosis for immunocompromised patients with new brain lesions found on radiographic imaging.
INTRODUCTION
Amebic encephalitis is an infrequently encountered infection of the CNS that is frequently fatal. Most cases of CNS amebiasis result from infection by the free-living amoebas Naegleria, Acanthamoeba, and Balamuthia. Infection with Naegleria fowleri usually is acquired by exposure to pond water, swimming pools, and man-made lakes and usually occurs in children and young adults who had been swimming during warm months. Acanthamoeba and Balamuthia mandrillaris usually cause granulomatous amebic encephalitis in immunocompromised individuals such as those infected with human immunodeficiency virus (HIV), chronically ill patients, organ transplant recipients, chronic alcoholics, patients receiving chemotherapy, patients with systemic lupus erythematous, and patients with primary immune disorders.
Acanthamoeba are free-living amoeba that are ubiquitous and have been isolated from soil, water, dust, and numerous household appliances (1, 2) . Many immunocompetent, healthy individuals demonstrate serum antibodies against Acanthamoeba, suggesting that exposure is common (3).
Patients with solid organ transplants (SOT) who develop Acanthamoeba encephalitis typically progress rapidly after the onset of neurological symptoms and the disease is typically fatal. The routes of entry include lower respiratory tract leading to amoebae invasion of the intravascular space, followed by hematogenous spread (1) . Additionally, amoebae may enter through defects in the skin and the olfactory neuroepithelium offers another route of CNS entry. Major virulence factors are adhesion, phagocytosis, plasminogen activation, acanthaporin proteins, superoxide dismutases, elastases, phospholipases, proteases, and glucosidases (1).
MATERIALS AND METHODS
A complete autopsy with no limitations was performed within 24 hours after death of the patient. A gross neuropathological examination was performed after the brain was fixed in 20% buffered formalin for $2 weeks. The cerebral hemispheres were sectioned coronally, the cerebellum was sectioned sagittally, and brainstem was cut perpendicular to the long axis. For light microscopy, samples were embedded in paraffin and 10-mm-thick sections were stained with hematoxylin and eosin and Luxol fast blue. The sections were taken from the hippocampus, basal ganglia, thalamus, medulla, pons, and cerebellum. A tissue block with amebic trophozoites identified on light microscopy was sent to the Centers for Disease Control where real-time polymerase chain reaction (PCR) testing and indirect immunofluorescence assays for Acanthamoeba species as well as B. mandrillaris and N. fowleri were performed.
RESULTS

Clinical Observations
A 69-year-old African American man with a past medical history of an orthotopic heart transplant 5 months prior, secondary to systemic amyloidosis, presented to an outside hospital with fever and altered mental status. These symptoms had been progressing over the course of a week. Previously, he had not had any significant complications related to the transplant and was currently taking tacrolimus, mycophenolate, and prednisone for immunosuppression. He was transferred to Duke University Medical Center due to concerns of possible encephalitis or other infectious etiologies and was empirically started on vancomycin, ampicillin, cefepime, and acyclovir.
An extensive infectious workup was performed the first day of admission to Duke. The testing included a urinalysis, PCR respiratory viral panel, blood cultures, hepatitis B and C testing, cryptococcal serum antigen, and CMV blood PCR. All results eventually came back negative. A lumbar puncture showed numerous neutrophils (51%) and RBCs (52%). Cerebrospinal fluid (CSF) bacterial and fungal cultures were negative as were tests for CMV, HSV, VZV, and enterovirus. CSF cytology did not reveal any additional abnormalities.
An MRI performed on the second day of admission showed extensive subependymal FLAIR signal hyperintensity throughout the entire ventricular system and a 6 Â 3 cm T2 signal hyperintensity located in the left caudate head that demonstrated peripheral enhancement and restricted diffusion (Fig. 1A) . He was transferred to the intensive care unit, was intubated, and had an extraventricular drain placed. Repeat CSF studies did not yield any additional information. Additional MRIs showed worsening ventriculitis and new focal lesions within the cerebral hemispheres and deep brain nuclei (Fig. 1B) .
Despite extensive workup to no avail, and broadspectrum coverage, the patient continued to clinically decline.
The family decided to withdraw care and he died 8 days after admission. The clinical team felt there was a short list of possible etiologies left given the negative workup and lack of clinical improvement despite empiric antibacterial/antifungal coverage. These included TB, JC virus, rabies, or a rapidly progressive malignant or inflammatory process. The family consented to a hospital autopsy.
Neuropathology
The brain demonstrated innumerable roughly circular, granular hemorrhagic lesions ranging from 0.5 to several centimeters in diameter which were frequently located in periventricular regions but also involved the subcortical nuclei including the caudate and thalamus, brainstem, and cerebellum ( Fig. 2A, B) . Histologic sections demonstrated numerous areas of parenchymal necrosis with abundant neutrophils. Numerous macrophages were present but well-formed granulomas were not identified. Mixed within the inflammation and necrotic debris were numerous large amebic trophozoites with a large prominent karyosome (Fig. 3A, B) . They frequently had a perivascular distribution. Tissue blocks were sent to the Centers for Disease Control for testing. Free-living amoeba real-time PCR for Acanthamoeba species as well as B. mandrillaris and N. fowleri was performed and the results were negative. However, indirect immunofluorescence as well as immunohistochemistry for Acanthamoeba species were positive. The negative PCR results were thought to be due to DNA degradation secondary to formalin fixation.
The rest of the organs did not show any sign of an infectious or inflammatory process. Perivascular amyloid was identified in numerous organs, which was consistent with the decedent's previous diagnosis of systemic amyloidosis. The heart did not show any evidence of acute cellular rejection. The eyes were examined as well and did not show any amebic organisms or keratitis. CT and MRI imaging usually demonstrate enhancing lesions within the cerebrum, subcortical white matter, basal ganglia, cerebellum, and brainstem. These findings are nonspecific and may also be seen in other CNS infections (1, 4) .
On autopsy examination the brains of patients with granulomatous amebic encephalitis are often swollen and congested. Multiple areas of softening and necrosis are often seen throughout the cerebral hemispheres, brainstem, and cerebellum. Microscopically, trophozoites and cysts can be seen in the necrotic areas and in the perivascular spaces. Our case was somewhat unique in that there was a marked ventriculitis that has not been described in the literature as a regularly recognized pattern of infection.
The relatively aggressive presentation in transplant recipients is possibly related to impairment of cell-mediated immunity secondary to immunosuppressive medications (4, 5) . All SOT patients who developed Acanthamoeba encephalitis reported in the literature received posttransplant immunosuppression that included different combinations of drugs such as tacrolimus, cyclosporine, mycophenolate mofetil, azathioprine, rituximab, and corticosteroids. Since macrophages and T-cells are thought to play a critical role in controlling Acanthamoeba infections, any impairment of their normal functions due to medications may increase the risk of serious infection (4, 5) .
Diagnosing Acanthamoeba encephalitis antemortem is very difficult as the symptoms are nonspecific and are easily mistaken for other bacterial, viral, or fungal diseases. Trophozoites may be identified on wet mount preparations of CSF. Acanthamoeba-specific PCR is available and this has been Amebic Encephalitis in a Heart Transplant used to diagnose Acanthamoeba encephalitis in at least 2 reported cases (4, 6) . Currently brain biopsy is required to give a definite antemortem diagnosis. If trophozoites or cysts are seen on routine histology, the diagnosis can be confirmed with immunohistochemistry or PCR. Acanthamoeba encephalitis is rare and there have been no therapeutic efficacy trials. The guidelines of the Infectious Disease Society of America recommend the use of trimethoprim-sulfamethoxazole in combination with rifampin and ketoconazole or the use of combination therapy with fluconazole plus sulfadiazine and pyrimethamine (7) . For B. mandrillaris infection, combinations of pentamidine, fluconazole, sulfadiazine, azithromycin, clarithromycin, and flucytosine has been described and was given to 2 patients who successfully recovered (8-10). When possible, surgical resection of brain lesions should be attempted but this is only likely to be helpful if there are very few lesions identified on imaging (4, 7). Therapy is not likely to be successful in fulminant cases once neurological symptoms have appeared and, unfortunately, this is the most common clinical presentation of the disease in patients with SOT. However, immediate treatment of CNS disease in more indolent cases may provide a chance of cure.
Conclusion
We report the thirteenth case of granulomatous amebic encephalitis caused by Acanthamoeba in a SOT recipient and the second in a heart transplant recipient. As organ transplants are becoming more common, it is necessary to increase awareness of this infectious process since antemortem diagnosis is difficult. We recommend autopsy examinations of all patients who have undergone SOTs and have died with an undiagnosed infectious or inflammatory CNS process.
